Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Home-use dual-light antibacterial therapy for peri-implant mucositis around full-arch implants

Official title: Efficacy of Home-Use Dual-Light Antimicrobial Photodynamic Therapy as an Adjunct to Supportive Peri-Implant Care in Patients With Peri-Implant Mucositis Around Screw-Retained Full-Arch Implant-Supported Prostheses: A Pilot Randomized Controlled Trial

Run by University of Medicine and Pharmacy at Ho Chi Minh City · NCT07763431 · Data updated 2026-11-12

This study tests whether a home-use dual-light device added to standard care can better control gum inflammation around full-arch dental implants than standard care alone.

More Peri-implant Mucositis trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment24 (estimated)
SponsorUniversity of Medicine and Pharmacy at Ho Chi Minh City
Academic / other
Locations1 site (Ho Chi Minh City, Cau Ong Lanh Ward)
StatusRecruiting
StartedOctober 19, 2026
Main results expectedMarch 10, 2027
Study endsJuly 10, 2027
Registry record updatedOctober 29, 2026
Trial IDNCT07763431 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18 years and older with screw-retained full-arch implant-supported prostheses and peri-implant mucositis, in good systemic health, non-smokers (for at least 6 months).

Probably not a fit

Patients with uncontrolled systemic conditions, recent antibiotic use, or poor ability to perform home hygiene may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This pilot randomized, two-arm, parallel-group trial evaluates the clinical and microbiological effects of adjunctive home-use dual-light antibacterial photodynamic therapy in adults with peri-implant mucositis who have screw-retained full-arch implant-supported prostheses. Participants receive usual professional cleaning and personalized oral hygiene instructions, with or without the at-home light device, over a short-term follow-up. The study aims to see if the device reduces gum bleeding, lowers probing depths, and decreases pathogenic bacteria compared with usual care alone. It is conducted at Odonto-Maxillo-Facial Hospital in Ho Chi Minh City under a single-blind design. The intervention combines antimicrobial photodynamic therapy with antibacterial blue light as a non-antibiotic adjunct to supportive peri-implant care.

Why it matters

Potential benefit: If successful, patients may experience better control of peri-implant inflammation and improved implant tissue health with a simple home-use device.

How similar studies have gone: Previous non-antibiotic adjuncts and photodynamic approaches have shown promise in similar peri-implant care settings, but home-use dual-light therapy is relatively novel for this specific indication.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults aged 18 years or older who agree to participate and provide written informed consent.
* Rehabilitated with a screw-retained full-arch implant-supported fixed prosthesis (All-on-4, All-on-6 or All-on-X) delivered at least 3 months before enrolment.
* Diagnosed with peri-implant mucositis according to the 2017 World Workshop case definitions.
* HbA1c below 7.0% and stable systemic health.
* Non-smoker for at least the preceding 6 months.
* Willing to attend all scheduled follow-up visits at 2 and 4 weeks and to comply with the home-use protocol.

Exclusion Criteria:

* Disability or severe motor impairment limiting the ability to perform the oral hygiene procedures required by the study.
* Long-term antibiotic therapy.
* Immunodeficiency.
* Long-term corticosteroid therapy.
* History of organ transplantation.
* Refusal to participate.

Where it's running

  • Odonto-Maxillo-Facial Hospital in Ho Chi Minh City
    Ho Chi Minh City, Cau Ong Lanh Ward, Vietnam
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.